General Information of the Compound
| Compound ID |
CP0425898
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(1-phenylpropyl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]pyrazolo[1,5-a]pyridine-5-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H33N7O
|
||||||||||||||||||
| Molecular Weight |
555.686
|
||||||||||||||||||
| Canonical SMILES |
CCCc1nn2ccc(cc2c1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1)C(=O)NC(CC)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C34H33N7O/c1-3-10-31-29(21-23-15-17-24(18-16-23)27-13-8-9-14-28(27)33-36-39-40-37-33)32-22-26(19-20-41(32)38-31)34(42)35-30(4-2)25-11-6-5-7-12-25/h5-9,11-20,22,30H,3-4,10,21H2,1-2H3,(H,35,42)(H,36,37,39,40)
Show/Hide
|
||||||||||||||||||
| InChIKey |
NYTRIMDNZMDDMC-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01919, Peroxisome proliferator-activated receptor alpha
Protein ID: PT03063, Peroxisome proliferator-activated receptor delta
Protein ID: PT00915, Peroxisome proliferator-activated receptor gamma
Protein ID: PT02973, Peroxisome proliferator-activated receptor gamma
Protein ID: PT01197, Type-1 angiotensin II receptor